Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1969 1
1984 1
1985 3
1986 2
1987 2
1989 3
1990 1
1991 1
2000 1
2002 1
2003 1
2004 4
2005 2
2006 3
2007 3
2008 6
2009 7
2010 3
2011 5
2012 6
2013 10
2014 7
2015 9
2016 8
2017 5
2018 8
2019 3
2020 4
2021 9
2022 6
2023 4
2024 9

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

114 results

Results by year

Filters applied: . Clear all
Page 1
Thoughts on the DSM-5.
Lecavalier L. Lecavalier L. Autism. 2013 Sep;17(5):507-9. doi: 10.1177/1362361313500865. Autism. 2013. PMID: 24137734 No abstract available.
Measuring anxiety as a treatment endpoint in youth with autism spectrum disorder.
Lecavalier L, Wood JJ, Halladay AK, Jones NE, Aman MG, Cook EH, Handen BL, King BH, Pearson DA, Hallett V, Sullivan KA, Grondhuis S, Bishop SL, Horrigan JP, Dawson G, Scahill L. Lecavalier L, et al. J Autism Dev Disord. 2014 May;44(5):1128-43. doi: 10.1007/s10803-013-1974-9. J Autism Dev Disord. 2014. PMID: 24158679 Free PMC article. Review.
Characterizing Sleep Problems in 16p11.2 Deletion and Duplication.
Kamara D, De Boeck P, Lecavalier L, Neuhaus E, Beauchaine TP. Kamara D, et al. Among authors: lecavalier l. J Autism Dev Disord. 2023 Apr;53(4):1462-1475. doi: 10.1007/s10803-021-05311-2. Epub 2021 Oct 11. J Autism Dev Disord. 2023. PMID: 34633643
A review of atomoxetine effects in young people with developmental disabilities.
Aman MG, Smith T, Arnold LE, Corbett-Dick P, Tumuluru R, Hollway JA, Hyman SL, Mendoza-Burcham M, Pan X, Mruzek DW, Lecavalier L, Levato L, Silverman LB, Handen B. Aman MG, et al. Among authors: lecavalier l. Res Dev Disabil. 2014 Jun;35(6):1412-24. doi: 10.1016/j.ridd.2014.03.006. Epub 2014 Apr 16. Res Dev Disabil. 2014. PMID: 24732041 Free PMC article. Review.
Outcome measures for clinical drug trials in autism.
Aman MG, Novotny S, Samango-Sprouse C, Lecavalier L, Leonard E, Gadow KD, King BH, Pearson DA, Gernsbacher MA, Chez M. Aman MG, et al. Among authors: lecavalier l. CNS Spectr. 2004 Jan;9(1):36-47. doi: 10.1017/s1092852900008348. CNS Spectr. 2004. PMID: 14999174 Free PMC article. Review.
Measuring repetitive behaviors as a treatment endpoint in youth with autism spectrum disorder.
Scahill L, Aman MG, Lecavalier L, Halladay AK, Bishop SL, Bodfish JW, Grondhuis S, Jones N, Horrigan JP, Cook EH, Handen BL, King BH, Pearson DA, McCracken JT, Sullivan KA, Dawson G. Scahill L, et al. Among authors: lecavalier l. Autism. 2015 Jan;19(1):38-52. doi: 10.1177/1362361313510069. Epub 2013 Nov 20. Autism. 2015. PMID: 24259748 Review.
114 results